References
- Amicarelli G, Shehi E, Makrigiorgos GM, et al (2007). FLAG assay as a novel method for real-time signal generation during PCR: application to detection and genotyping of KRAS codon 12 mutations. Nucleic Acids Res, 35, 131. https://doi.org/10.1093/nar/gkm809
- Antonio Jimeno, Manuel Hidalgo (2006). Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer. Mol Cancer Ther, 5, 787-96. https://doi.org/10.1158/1535-7163.MCT-06-0005
- Arvanitakis M, Van Laethem JL, Parma J, et al (2004). Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with KRAS gene mutation. Endoscopy, 36, 535-42. https://doi.org/10.1055/s-2004-814401
- Boldrini L, Gisfredi S, Ursino S, et al (2007). Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis. J Thorac Oncol, 2, 1086-90. https://doi.org/10.1097/JTO.0b013e31815ba1fa
- Chen CY, Shiesh SC, Wu SJ (2004). Rapid detection of KRAS mutations in bile by peptide nucleic acid-mediated PCR clamping and melting curve analysis: comparison with restriction fragment length polymorphism analysis. Clin Chem, 50, 481-9. https://doi.org/10.1373/clinchem.2003.024505
- Dawood S (2010). Novel biomarkers of metastatic cancer. expert review of molecular diagnostics. Expert Rev Mol Diagn. 10, 581-90. https://doi.org/10.1586/erm.10.35
- Deramaudt T, Rustgi AK. (2005). Mutant KRAS in the initiation of pancreatic cancer. Biochim Biophys Acta, 1756, 97-101.
- Di Fiore F, Blanchard F, Charbonnier F, et al (2007). Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy. Br J Cancer, 96, 1166-9. https://doi.org/10.1038/sj.bjc.6603685
- Eijk RV, Puijenbroek MV, Amiet R, et al (2010). Chhatta sensitive and specific KRAS somatic mutation analysis on whole-genome amplified DNA from archival tissues. J Molecular Diagnostics, 12, 27-34. https://doi.org/10.2353/jmoldx.2010.090028
- Gary Y, Timothy D, Wagner, et al (2005). Multimodality approaches for pancreatic cancer. Cancer J Clin, 55, 352-67. https://doi.org/10.3322/canjclin.55.6.352
- Guo W, Zhang C, Wu J, et al (2012). Unlabeled-probe high-resolution melting to detect KRAS codon 12 and 13 mutations in pancreatic adenocarcinoma tissues. Clin Chem Lab Med, 50, 1035-40.
- Habermann J, Bunger K, Bunger S, et al (2011). Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview. J Cancer Res Clin Oncol, 137, 375-89. https://doi.org/10.1007/s00432-010-0965-x
- Huang C, Wang WM, Gong JP, et al (2013). Oncogenesis and the clinical significance of K-ras in pancreatic adenocarcinoma. Asian Pac J Cancer Prev, 14, 2699-701. https://doi.org/10.7314/APJCP.2013.14.5.2699
- Karnoub AE, Weinberg RA (2008). RAS oncogenes: split personalities. Nat Rev Mol Cell Biol, 9, 517-31. https://doi.org/10.1038/nrm2438
- Krypuy M, Newnham GM , Thomas DM, et al (2006). High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer. BMC Cancer, 6, 295-306. https://doi.org/10.1186/1471-2407-6-295
- Laurent-Puig P, Lecomte T, Berger A, et al (2002). Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. Intl J Cancer, 100, 542-8. https://doi.org/10.1002/ijc.10526
- Liew M, Pryor R, Palais R, et al (2004). Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons. Clin Chem, 50, 1156-64. https://doi.org/10.1373/clinchem.2004.032136
- Li J, Wang L, Mamon H, et al (2008). Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing. Nature Med, 14, 579-84. https://doi.org/10.1038/nm1708
- Lipsky RH, Mazzanti CM, Rudolph JG, et al (2001). DNA melting analysis for detection of single nucleotide polymorphisms. Clin Chem, 47, 635-44.
- Lokshin A, Brand E, Nolen RE, et al (2011). Serum biomarker panels for the detection of pancreatic cancer. Clin Cancer Res, 17, 805-16. https://doi.org/10.1158/1078-0432.CCR-10-0248
- Maheswaran S, Sequist LV, Nagrath S, et al (2008). Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med, 359, 366-77. https://doi.org/10.1056/NEJMoa0800668
- Malfertheiner P, Fry L, Monkemuller CK, et al (2008). Molecular markers of pancreatic cancer: development and clinical relevance. Langenbecks Arch Surg, 393, 883-90. https://doi.org/10.1007/s00423-007-0276-0
- Massarelli E, Varella-Garcia M, Tang X, et al (2007). KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. Clin Cancer Res, 13, 2890-6. https://doi.org/10.1158/1078-0432.CCR-06-3043
- Ogino S, Kawasaki T, Brahmandam M, et al (2005). Sensitive sequencing method for KRAS mutation detection by pyrosequencing. J Mol Diagn, 7, 413-21. https://doi.org/10.1016/S1525-1578(10)60571-5
- Paez JG, Janne PA, Lee JC, et al (2004). EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science, 304, 1497-500. https://doi.org/10.1126/science.1099314
- Pitman MB, Lewandrowski K, Shen J, et al (2010). Fernandez-del Castillo, C. Pancreatic cysts preoperative diagnosis and clinical management. Cancer Cytopathology, 118, 1-13. https://doi.org/10.1002/cncy.20059
- Robert M, Beazley, lsidore Cohn, Jr (1981). Pancreatic cancer. CA Cancer J Clin, 31, 346-58. https://doi.org/10.3322/canjclin.31.6.346
- Maheswaran S, Sequist LV, Nagrath S, et al (2008). Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med, 359, 366-77. https://doi.org/10.1056/NEJMoa0800668
- Vossen RH, Aten E, Roos A, et al (2009). High-resolution melting analysis (HRMA)-more than just sequence variant screening. Human Mutation, 30, 860-6. https://doi.org/10.1002/humu.21019
- Wittwer CT, Reed GH, Gundry CN, et al (2003). High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem, 49, 853-60. https://doi.org/10.1373/49.6.853
- Wu CC, Hsu HY, Liu HP, et al (2008). Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications. Cancer, 113, 3199-208. https://doi.org/10.1002/cncr.23925
Cited by
- Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy vol.6, pp.2046-1402, 2017, https://doi.org/10.12688/f1000research.11371.1